So, Selumetinib is this MEK inhibitor that’s been okayed for folks with neurofibromatosis type 1 and those who have symptoms from their plexiform neurofibromas. It does its thing by stopping MEK signaling, which is a big deal in this MAPK pathway thing.
Available in two strengths 10 mg and 25 mg capsules, the recommended dosage is 25 mg/m² administered twice daily on an empty stomach. Each pill’s got its own time to go down, and you get these 60-capsule bottles, making it easy to stick to your treatment plan.
Reviews
There are no reviews yet.